FIELD: immunology.
SUBSTANCE: immunogenic product is proposed, which is truncated mutein oligomer Aβ for inducing an immune response against amyloidosis, as well as a composition for treating and preventing amyloidosis containing such a product.
EFFECT: present invention can be further used in therapy of Alzheimer’s disease or Down’s syndrome.
14 cl, 4 dwg, 10 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN LIPOCALIN 2 MUTEINS (Lcn2, hNGAL) WITH TARGETED AFFINITY | 2019 |
|
RU2804336C2 |
| HUMAN LIPOLOCAL 2 MALLETES (LCN2, HNGAL) WITH AFFINITY FOR SPECIFIC TARGET | 2010 |
|
RU2707126C2 |
| MUTEINS OF HUMAN LIPOCALIN 2 (LCN2, HNGAL) WITH AFFINITY TO CERTAIN TARGET | 2010 |
|
RU2564125C2 |
| PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA | 2013 |
|
RU2811687C2 |
| ANTISUBSTANCES AGAINST GLOBULOMER Aβ, THEIR ANTIGEN-BINDING PARTS, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, WAYS OF PRODUCTION OF MENTIONED ANTISUBSTANCES, COMPOSITIONS CONTAINING MENTIONED ANTISUBSTANCES, APPLICATION OF MENTIONED ANTISUBSTANCES AND WAYS OF APPLICATION OF MENTIONED ANTISUBSTANCES | 2006 |
|
RU2442793C2 |
| ANTI-ADDL MONOCLONAL ANTIBODY AND USE THEREOF | 2011 |
|
RU2567808C2 |
| MUTEINS OF HUMAN LIPOCALIN 2 WITH AFFINITY FOR GLYPICAN-3 (GPC3) | 2016 |
|
RU2756318C2 |
| MONOCLONAL ANTIBODIES AND APPLICATIONS THEREOF | 2006 |
|
RU2432362C2 |
| PROTEINS BINDING TO HEPCIDIN | 2011 |
|
RU2625011C2 |
| NOVEL SPECIFIC BINDING POLYPEPTIDES AND ROUTES OF USE THEREOF | 2015 |
|
RU2723034C2 |
